Skip to main content
Antonio Martin Jimenez-Jimenez on Muck Rack

Antonio Martin Jimenez-Jimenez

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Antonio Martin

Contact Antonio Martin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide | Journal of Clinical Oncology

|
By Bronwen E. Shaw, Antonio Martin Jimenez-Jimenez, Linda Burns, Brent R. Logan
| ascopubs.org
PURPOSE Hematopoietic cell transplantation (HCT) is curative for hematologic disorders, but outcomes are historically inferior when using HLA-mismatched donors. Despite unrelated donor registries listing > 38 million volunteers, 25%-80% of US patients lack an HLA-matched unrelated donor, with significant disparity across ethnic groups.
Open in Who Shared Issue with article?
See all 1 articles